Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 721 of 6351
-
Heart attack prevention hope for rare cholesterol disorder
Disease control OngoingThis observational, multicenter, retrospective and prospective study aims to evaluate the effect of lomitapide treatment on Major Adverse Cardiovascular Events (MACE) in patients with Homozygous Familial Hypercholesterolemia (HoFH). HoFH is a rare genetic disorder characterized …
Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Targeted radiation zaps Hard-to-Treat cancers in early trial
Disease control Stopped earlyThe purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-EVS459 and the safety and imaging properties of \[68Ga\]Ga-EVS459 in patients aged ≥ 18 years with advanced high-grade serous ovarian cancer (OC) or locally advanc…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can melatonin and morning light reset the body clock to fight excessive sleepiness?
Disease control Recruiting nowIdiopathic hypersomnia (IH) is a chronic disabling disorder characterized by excessive daytime sleepiness (EDS), prolonged nighttime sleep and sleep inertia. IH is a rare disorder, estimated around 0.05%, yet its true prevalence remains unknown. Disease onset occurs most often du…
Phase 2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a livestock dewormer beat whipworm in people? a trial puts oxfendazole to the test.
Cure Recruiting nowThis is a Phase 2 trial to evaluate the efficacy of different doses of oxfendazole versus a single dose of albendazole in curing or reducing the egg burden in subjects with T. trichiura infections. 249 subjects will be randomized in a 1:1:1 ratio to one of three dose-groups to re…
Phase 2 • Sponsor: Asociacion Benefica Prisma • Aim: Cure
Last updated Jul 30, 2026 00:00 UTC
-
Could a child's doctor visit spark a parent's quit-smoking journey?
Prevention Recruiting nowThe goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household membe…
Sponsor: Children's Hospital of Philadelphia • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
New combo therapy aims to tackle tough prostate cancer
Disease control Recruiting nowThis phase II trial tests how well relugolix and enzalutamide, in combination with radiation therapy, works in treating patients with very high risk prostate cancer. Relugolix is a form of androgen deprivation therapy. It prevents the release of testosterone, a hormone required t…
Phase 2 • Sponsor: Sean Sachdev • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Brain pacemaker may curb risky behaviors in Parkinson's patients
Disease control Recruiting nowThe focus of the study is on patients Parkinson's disease showing as well behavioral disorders that can be described as pathological and are summarized under the term impulse control disorder (ICD). Changes in behavior and also pathological disorders are a common side effect of t…
Sponsor: University of Kiel • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New radiation technique aims to spare healthy tissue in cervical cancer
Disease control Recruiting nowThis study aims to evaluate the clinical efficacy and safety of online adaptive radiotherapy for cervical cancer patients received radical radiotherapy. By comparing with image-guided radiotherapy, the study explores the potential advantages of online adaptive radiotherapy in red…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Chemo-Free hope for HER2+ breast cancer patients in new trial
Disease control OngoingThis study aims to identify HER2-positive early-stage breast cancer patients who could benefit from neoadjuvant treatment using PHESGO™ (pertuzumab and trastuzumab) without chemotherapy. The approach involves utilizing specific biomarkers (HR and HER2 IHC status) to select partic…
Phase 2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Experimental drug combo aims to shrink aggressive breast tumors before surgery
Disease control Recruiting nowThis is a Phase II trial to assess efficacy and feasibility of pembrolizumab + INBRX-106 as an induction therapy preceding neoadjuvant therapy.
Phase 2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Magic mushrooms take on depression: new trial tests psilocybin with antidepressants
Symptom relief Recruiting nowThis Phase 2a pilot, exploratory, randomized, double-blind, placebo-controlled, parallel-group trial will estimate whether concurrent fluoxetine alters the antidepressant effect, acute psychedelic experience, or safety of a psychedelic-assisted psychotherapy session in adults wit…
Phase 1/2 • Sponsor: Federal University of Latin American Integration • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
A personal nurse and a plan: could this ease the daily burden of arthritis?
Symptom relief Recruiting nowBackground: Patients with inflammatory arthritis (IA) experience substantial impact of their disease despite optimal pharmacological treatment. To be able to manage these challenges effectively, patients require tailored self-management support from various professionals. We thu…
Sponsor: The Danish Center for Expertise in Rheumatology • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Major trial aims to stop kidney failure in its tracks
Disease control Recruiting nowCAPTIVATE is an international, multi-centre, Phase III, adaptive, platform, randomised controlled trial in people with chronic kidney disease (CKD). CAPTIVATE aims to find the best treatment, or combination of treatments, that slow the progression of CKD so that fewer people dev…
Phase 3 • Sponsor: The George Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for Crohn's: four targeted drugs enter Mid-Stage trial
Disease control Recruiting nowCrohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms including belly pain, diarrhea, tiredness, and weight loss. Treatments are availa…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Will a tiny sensor boost Well-Being in type 2 diabetes?
Symptom relief CompletedBackground: Diabetes Mellitus (DM) is a chronic disease that affects millions of people worldwide. More than 95% of cases are type 2 diabetes mellitus (T2DM). In recent years, diabetes management has evolved with the introduction of continuous glucose monitoring (CGM) devices. Th…
Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
No-Needle chemo patch takes aim at skin cancer
Disease control CompletedThis Phase 2 study evaluates the safety and efficacy of microneedle array (MNA) alone and in combination with two dose levels of doxorubicin (100µg and 200µg) in patients with nodular basal cell carcinoma. Efficacy is assessed using both clinical (visual) and histological endpoin…
Phase 2 • Sponsor: SkinJect, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New shot could cut IV feeding for short bowel patients
Disease control Recruiting nowThe main aim of this clinical trial is to assess the efficacy and safety of PJ009 in patients aged ≥14 with short bowel syndrome (SBS) requiring parenteral nutrition. The main questions it aims to answer are: * How effective is PJ009 in treating short bowel syndrome? * Is PJ009 …
Phase 3 • Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Immunotherapy plus chemo shows promise for esophageal cancer before surgery
Disease control Recruiting nowThis is a domestic exploratory, single-arm clinical study enrolling patients with histologically or cytologically confirmed locally advanced esophageal squamous cell carcinoma (ESCC), aiming to evaluate the efficacy and safety of neoadjuvant adebrelimab plus chemotherapy for loca…
Phase 2 • Sponsor: The Affiliated Hospital of Putian University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for advanced cancer: experimental drug DB-1419 enters human trials
Disease control Recruiting nowA Phase 1/2a First-in-Human Study of DB-1419 in Advanced/Metastatic Solid Tumors
Phase 1/2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could an osteoporosis drug shield the pancreas in type 1 diabetes?
Disease control Recruiting nowType 1 diabetes (T1D) arises from abnormal immune cell-mediated injury to beta cells that make insulin. The injured beta cells can then no longer make the needed amount of insulin to stay healthy. However, in the early stages of T1D, some beta cells are still alive and functionin…
Phase 1/2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC